Royalty on Net Sales. In partial consideration for any Exclusive Commercial License granted by Medarex, Celldex shall pay to Medarex a royalty on annual (based on a calendar year) aggregate worldwide Net Sales of Products on a Product-by-Product basis as follows: Portion of Annual Net Sales [*****] [*****] Portion of Annual Net Sales [*****] [*****] Portion of Annual Net Sales [*****] [*****]
Appears in 2 contracts
Samples: Research and Commercialization Agreement (Celldex Therapeutics Inc), Research and Commercialization Agreement (Celldex Therapeutics Inc)
Royalty on Net Sales. In partial consideration for any Exclusive Commercial License granted by Medarex, Celldex shall pay to Medarex a royalty on annual (based on a calendar year) aggregate worldwide Net Sales of Products on a Product-by-Product basis as follows: Portion of Annual Net Sales [[ ****** ] [[ ****** ] Portion of Annual Net Sales [[ ****** ] [[ ****** ] Portion of Annual Net Sales [[ ****** ] [[ ****** ]
Appears in 1 contract
Samples: Research and Commercialization Agreement (Avant Immunotherapeutics Inc)
Royalty on Net Sales. In partial consideration for any Exclusive Commercial License granted by Medarex, Celldex shall pay to Medarex a royalty on annual (based on a calendar year) aggregate worldwide Net Sales of Products on a Product-by-Product basis as follows: Portion of Annual Net Sales [*****] [*****] Portion of Annual Net Sales [*****] [*****] Portion of Annual Net Sales [*****] [*****]Sales
Appears in 1 contract
Samples: Research and Commercialization Agreement (Celldex Therapeutics Inc)
